Umthengisi weTofacitinib CAS:477600-75-2
I-Tofacitinib liyeza lokunyanga isifo samathambo esibizwa ngokuba yi-rheumatoid arthritis (RA), i-psoriasis, isifo samathumbu esidumbileyo, kunye nezinye izifo ze-immunological, kunye nokuthintela ukwaliwa kokufakelwa kwamalungu omzimba. Ingumthinteli we-enzyme iJanus kinase 3 (JAK3), oko kuthetha ukuba iphazamisa indlela yokubonisa ye-JAK-STAT edlulisela ulwazi ngaphandle kweseli kwi-nucleus yeseli, ichaphazela ukubhalwa kwe-DNA. Kutshanje iboniswe kwimodeli ye-murine ye-arthritis esekwe, i-tofacitinib iphucula ngokukhawuleza isifo ngokuthintela ukuveliswa kwezinto ezibangela ukudumba kunye nokuthintela ii-genes ezixhomekeke kwi-STAT1 kwizicubu ezidibeneyo. Oku kusebenza kakuhle kule modeli yesifo kunxulumene nokuthintela zombini iindlela zokubonisa ze-JAK1 kunye ne-3, nto leyo ebonisa ukuba i-tofacitinib inokuba luncedo kunyango ngeendlela ezingezizo zokuthintela i-JAK3 kuphela.
| Ukwakhiwa | C16H20N6O |
| Uvavanyo | 99% |
| Inkangeleko | Umgubo omhlophe ongacacanga |
| Inombolo ye-CAS | 477600-75-2 |
| Ukupakisha | 25KG |
| Beka ubomi kwishelufa | iminyaka eyi-2 |
| Indawo yokugcina izinto | Gcina kwindawo epholileyo neyomileyo |
| Isiqinisekiso | I-ISO. |








